Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 4, 2023. (Total: 223640Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 6 (of 6 Records)

Query Trace: Macular Degeneration and FLT1[original query]
The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).
Transactions of the American Ophthalmological Society 2011 Dec 109 115-56.
Francis Peter Jam
Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.
Ophthalmology 2014 Apr 121 (4): 905-10.
Hermann Manuel M, van Asten Freekje, Muether Philipp S, Smailhodzic Dzenita, Lichtner Peter, Hoyng Carel B, Kirchhof Bernd, Grefkes Christian, den Hollander Anneke I, Fauser Sasc
FLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expression.
Investigative ophthalmology & visual science 2014 Jun 55 (6): 3543-54.
Owen Leah A, Morrison Margaux A, Ahn Jeeyun, Woo Se Joon, Sato Hajime, Robinson Rosann, Morgan Denise J, Zacharaki Fani, Simeonova Marina, Uehara Hironori, Chakravarthy Usha, Hogg Ruth E, Ambati Balamurali K, Kotoula Maria, Baehr Wolfgang, Haider Neena B, Silvestri Giuliana, Miller Joan W, Tsironi Evangelia E, Farrer Lindsay A, Kim Ivana K, Park Kyu Hyung, DeAngelis Margaret
Evaluation of sFLT1 protein levels in human eyes with the FLT1 rs9943922 polymorphism.
Ophthalmic genetics 2017 Sep 1-5.
Chirco Kathleen R, Lewis Carly J, Scheetz Todd E, Johnston Rebecca M, Tucker Budd A, Stone Edwin M, Fingert John H, Mullins Robert
Genetic Polymorphisms in VEGFR Coding Genes (FLT1/KDR) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients.
Pharmaceutics 2022 7 14 (8): .
Blánquez-Martínez David, Díaz-Villamarín Xando, García-Rodríguez Sonia, Antúnez-Rodríguez Alba, Pozo-Agundo Ana, Martínez-González Luis Javier, Muñoz-Ávila José Ignacio, Dávila-Fajardo Cristina Luc
Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration.
Investigative ophthalmology & visual science 2023 10 64 (13): 34.
Laura García-Quintanilla, Pablo Almuiña-Varela, Olalla Maroñas, Almudena Gil-Rodriguez, María José Rodríguez-Cid, María Gil-Martinez, Maximino J Abraldes, Francisco Gómez-Ulla de Irazazabal, Miguel González-Barcia, Cristina Mondelo-Garcia, Raquel Cruz, Ana Estany-Gestal, Maribel Fernández-Rodríguez, Anxo Fernández-Ferrei
TOP